Baumann MU, Schneider H, Malek A, Palta V, Surbek DV, Sager R, Zamudio S, Illsley NP
Reported side effects are rare and mild , but may include: Temporary injection site redness Headache or fatigue (usually transient) Mild dizziness during first doses Importantly, Epithalon is not FDA-approved for any condition and is used for research purposes only under the direction of a licensed provider
Research involving this compound typically focuses on BPC-157 and TB-500 pathway-combination research, with attention to receptor activity, cellular signaling, and measurable pathway response in experimental models
10.1080/15548627.2018.1507439 Autophagy 143 ZhangY.FangF.GoldsteinJ